HYBRID EVENT: Join us in person in Barcelona, Spain or attend virtually from anywhere.
10th Edition of World Congress on Infectious Diseases
June 25-27, 2026 | Barcelona, Spain
Beta Lactam Antibiotics
Beta Lactam Antibiotics
Beta-lactam antibiotics play a pivotal role in addressing microbial threats, demonstrating versatility in treating a wide array of bacterial infections. Carbapenems, a potent subgroup, exhibit broad-spectrum activity against gram-positive and gram-negative bacteria, making them valuable in severe infections. Monobactams, such as aztreonam, are notable for their specificity against gram-negative aerobes, minimizing collateral damage to beneficial flora. Despite their efficacy, the emergence of beta-lactamases poses a challenge, prompting continuous research for novel compounds and combination therapies to combat resistance. The ongoing evolution of beta-lactam antibiotics underscores their significance in modern antimicrobial strategies.
Committee Members
Francis J Castellino
University of Notre Dame, United States
Ranjan Ramasamy
ID-FISH Technology, United States
Yazdan Mirzanejad
University of British Columbia, Canada Infection 2026 Speakers
Alexis Torres Rodriguez
NewYork-Presbyterian Queens Hospital, United States
Sasha Leibholz
New York Presbyterian Columbia/Cornell, United States
Hana Raza
Mclaren Oakland Hospital, United States
Terri Menser
Mayo Clinic, United StatesSubmit your abstract Today
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation